Mark S Leventhal, a director of ProPhase Labs, recently acquired 200,000 shares of the company. The buys took place at prices ranging from $1.31 to $1.40 per share, on dates ranging from June 05 to June 08, 2015. Leventhal now owns 661,980 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.39, inclusive.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.40, inclusive.
The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a c
haritable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017